ATHE Competitors & Alternatives
Compare Alterity Therapeutics Ltd with similar stocks in the same industry
Biotechnology
ATHE
Main Stock$4.46
Tradestie Score
57
Market Cap
$71.60M
Revenue Growth
0.7%
Analyst Upside
+184.2%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.60
|
$154.27M | - | 61 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.81
|
$133.50M | - | 54 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.29
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.27
|
$110.20M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.30
|
$71.69M | - | 49 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.42
|
$67.94M | - | 52 | Compare |
|
EDSA
Edesa Biotech, Inc. Common Shares
|
$5.23
|
$18.87M | - | 46 | Compare |
|
PHIO
Phio Pharmaceuticals Corp. Common Stock
|
$1.03
|
$13.86M | - | 45 | Compare |
|
IMRN
Immuron Limited American Depositary Shares
|
$1.06
|
$12.81M | - | 49 | Compare |
|
ADIL
Adial Pharmaceuticals, Inc
|
$3.64
|
$8.08M | - | 59 | Compare |
More ATHE Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry